share_log

金达威(002626.SZ):“一种烟酰胺腺嘌呤二核苷酸的制备方法”获发明专利

Jin Dawei (002626.SZ): “A method for preparing nicotinamide adenine dinucleotide” obtained an invention patent

Gelonghui Finance ·  Apr 11 04:04

Gelonghui, April 11 | Jin Dawei (002626.SZ) announced that the company's holding subsidiary Jiangsu Chengxin Pharmaceutical Co., Ltd., the company and its wholly-owned subsidiary Inner Mongolia Jindaway Pharmaceutical Co., Ltd., and its wholly-owned subsidiary Jindaway Biotechnology (Jiangsu) Co., Ltd. recently each received an invention patent certificate issued by the State Intellectual Property Office, which is a preparation method for nicotinamide adenine dinucleotide.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment